OOIR: Observatory of International Research

Papers

(The H4-Index of Neuropharmacology is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Conditional deletion of the AMPA-GluA1 and NMDA-GluN1 receptor subunit genes in midbrain D1 neurons does not alter cocaine reward in mice	273
Dose-dependent suppression of hippocampal contextual memory formation, place cells, and spatial engrams by the NMDAR antagonist (R)-CPP	104
Chemogenetic inhibition of locus coeruleus to rostromedial tegmental nucleus noradrenergic pathway increases light cycle ethanol drinking in male and female mice and blunts ethanol-induced CTA	91
The sensation seeking trait confers a dormant susceptibility to addiction that is revealed by intermittent cocaine self-administration in rats	77
Impact of prenatal amoxicillin exposure on hippocampal development deficiency	70
Postictal hypoxia involves reactive oxygen species and is ameliorated by chronic mitochondrial uncoupling	65
The PDE4 inhibitor apremilast modulates ethanol responses in Gabrb1-S409A knock-in mice via PKA-dependent and independent mechanisms	65
Editorial Board	64
Editorial Board	64
Pre-traumatic antibiotic-induced microbial depletion reduces neuroinflammation in acute murine traumatic brain injury	62
TRPV1 modulation of contextual fear memory depends on stimulus intensity and endocannabinoid signalling in the dorsal hippocampus	61
Evidence for low affinity of GABA at the vesicular monoamine transporter VMAT2 – Implications for transmitter co-release from dopamine neurons	61
Serotonin modulates social responses to stressed conspecifics via insular 5-HT2C receptors in rat	61
Jeffrey Clifton Watkins FRS - The father of the glutamate receptor	61
Editorial Board	61
Polysorbate 80 coated chitosan nanoparticles for delivery of α-melanocyte stimulating hormone analog (NDP-MSH) to the brain reverse cognitive impairment related to neuroinflammation produced by a high	60
Antidepressants in the post-ketamine Era: Pharmacological approaches targeting the glutamatergic system	60
Novel chimeric peptides of endomorphin-2 and the active fragments of ghrelin exhibit blood-brain barrier permeability and central antinociceptive effects with reduced opioid-related side effects	59
Adenosine is released during thalamic oscillations to provide negative feedback control	57
Neuropeptide apelin presented in the dopaminergic neurons modulates the neuronal excitability in the substantia nigra pars compacta	57
Genetic inactivation of the CRF2 receptor eliminates morphine-induced sociability deficits in female mice	56
PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation	55
Electrophysiological analysis of paraventricular thalamic neurons co-expressing kappa and mu opioid receptors	55
Corticotropin-releasing factor potentiates glutamatergic input and excitability of presympathetic neurons in the hypothalamus in spontaneously hypertensive rats	55
Specific sub-regions of the longitudinal axis of the hippocampus mediate behavioural responses to chronic psychosocial stress	54

R (−)-methoxetamine exerts rapid and sustained antidepressant effects and fewer behavioral side effects relative to S (+)-methoxetamine	53
Ageing-related changes in the regulation of microglia and their interaction with neurons	53
Strategies to dissect microglia-synaptic interactions during aging and in Alzheimer's disease	53
Neuronal and therapeutic perspectives on empathic pain: A rational insight	52
Microglia phagocytosis of PNNs mediates PV-positive interneuron dysfunction and associated gamma oscillations in neuroinflammation-induced cognitive impairment in mice	51
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl	51
Kappa opioid receptor modulation of endometriosis pain in mice	50
Chronopharmacokinetics of the antidepressant paroxetine: An in vitro and in vivo approach	50
Prenatal exposure to valproic acid reduces synaptic δ-catenin levels and disrupts ultrasonic vocalization in neonates	49
Examination of the effects of vitexin and vitexin-loaded solid lipid nanoparticles on neuropathic pain and possible mechanisms of action	47
Temporal dynamics of BDNF signaling recruitment in the rat prefrontal cortex and hippocampus following a single infusion of a translational dose of ketamine	47
Ferroptosis and cognitive impairment: Unraveling the link and potential therapeutic targets	46
Characterization of opioidergic mechanisms related to the anti-migraine effect of vagus nerve stimulation	46
Potential role of the hydroxyl carboxylic acid receptor type 2 (HCAR2) in microglia pathophysiology: A possible cross-talk with C-X-C chemokine receptor 1 (CXCR1)	46
CB1 receptor expression and signaling are required for dexamethasone-induced aversive memory consolidation	45
Transcriptome changes in the nucleus of the solitary tract induced by repeated stress, alcohol dependence, or stress-induced drinking in dependent mice	44
Determining the neuronal ensembles underlying sex-specific social impairments following adolescent intermittent ethanol exposure	43
Exploring ketamine’s reinforcement, cue-induced reinstatement, and nucleus accumbens cFos activation in male and female long evans rats	43